ABOUT THIS REPORT    |    HOME    |
In the Spotlight 2017 Clover's vision and mission Strategy Clover’s Timeline Geographic footprint Group structure Shareholders information Directorate and management
Chairman’s report Chief Executive’s report Chief Financial Officer’s report Six year financial review Financial highlights
How Clover creates value today Overview of Clover’s value creation process Reporting on the six capitals Clover’s business model Human capital Natural capital Manufactured capital Intellectual capital Social and relationship capital Financial capital How Clover sustains value for Tomorrow Clover’s future value creation philosophy Human capital Natural capital Manufactured capital Intellectual capital Social and relationship capital Combined Assurance
Report on governance, risk and compliance Clover’s risk universe King III Index Report on remuneration Clover’s Remuneration Policy Remuneration mix Approach to executive remuneration Approach to non-executive director’s remuneration Legacy scheme SARs issues
Audit and risk committee report Approval of the financial statement Certificate by Company Secretary Independent Auditor’s report Directors’ report Consolidated statement of comprehensive income Consolidated statement of financial position Consolidated statement of changes in equity Consolidated statement of cash flows Notes to the consolidated financial statements Notes 1 - 10 Notes 11 - 20 Notes 21 - 30 Notes 31 - 34 Abbreviations Definitions
  • Clover’s way better story
  • Business review
  • How clover creates value and reporting on the six capitals
  • Governance, risk and compliance, and remuneration reports
  • Annual financial statements
  •   BACK
  • In the Spotlight 2017
  • Clover's vision and mission
  • Strategy
  • Clover’s Timeline
  • Geographic footprint
  • Group structure
  • Shareholders information
  • Directorate and management
  •   BACK
  • Chairman’s report
  • Chief Executive’s report
  • Chief Financial Officer’s report
  • Six year financial review
  • Financial highlights
  •   BACK
  • How Clover creates value today
  • Overview of Clover’s value creation process
  • Reporting on the six capitals
  • Clover’s business model
  • Human capital
  • Natural capital
  • Manufactured capital
  • Intellectual capital
  • Social and relationship capital
  • Financial capital
  • How Clover sustains value for Tomorrow
  • Clover’s future value creation philosophy
  • Human capital
  • Natural capital
  • Manufactured capital
  • Intellectual capital
  • Social and relationship capital
  • Combined Assurance
  •   BACK
  • Report on governance, risk and compliance
  • Clover’s risk universe
  • King III Index
  • Report on remuneration
  • Clover’s Remuneration Policy
  • Remuneration mix
  • Approach to executive remuneration
  • Approach to non-executive director’s remuneration
  • Legacy scheme SARs issues
  •   BACK
  • Combined Assurance
  •   BACK
  • Audit and risk committee report
  • Approval of the financial statement
  • Certificate by Company Secretary
  • Independent Auditor’s report
  • Directors’ report
  • Consolidated statement of comprehensive income
  • Consolidated statement of financial position
  • Consolidated statement of changes in equity
  • Consolidated statement of cash flows
  • Notes to the consolidated financial statements
  • Notes 1 - 10
  • Notes 11 - 20
  • Notes 21 - 30
  • Notes 31 - 34
  • Abbreviations
  • Definitions

Annual financial statements

  • Audit and risk committee report
  • Approval of the financial statement
  • Certificate by Company Secretary
  • Independent Auditor’s report
  • Directors’ report
  • Consolidated statement of comprehensive income
  • Consolidated statement of financial position
  • Consolidated statement of changes in equity
  • Consolidated statement of cash flows
  • Notes to the consolidated financial statements
  • Notes 1 - 10
  • Notes 11 - 20
  • Notes 21 - 30
  • Notes 31 - 34
  • Abbreviations
  • Definitions

Consolidated statements of cash flows

for the year ended 30 June 2017
GROUP       COMPANY
                 
2017
R’000
2016
R’000
   Notes 2017
R’000
2016
R’000
      Operating activities           
199 847  465 893  Profit before tax     124 269  135 432 
199 847  465 893  Profit before tax      124 269  135 432 
      Adjustments to reconcile profit before tax to net cash flow          
      Adjustment for non-cash items:          
183 366  166 941  Depreciation of property, plant and equipment      1  1 
22 816  21 680  Amortisation of intangible assets          
6  8  Depreciation of investment properties           
(1 422) –  Fair value adjustments on call options          
4 100  –  Software licences written off          
(9 270) –  Profit on the sale of Lactolab          
336  –  Deconsolidation of Lactolab          
(33 404) (20 869) Profit on disposal and scrapping of assets     –  ( 521)
(15 889) 21 036  Unrealised loss on financial instruments          
(9 321) (9 075) Unrealised foreign exchange gain  6.2       
11 232  (27 833) Realised foreign exchange loss/(gain) 6.2-6.3       
–  (1 721) Bargain purchase on the investment in Clover Good Hope  3.1       
–  28 366  Release of foreign currency translation reserve in abandonment of foreign operation  6.3       
(7 295) 38  Share of profit of joint venture – net of dividend paid  4       
2 213  1 120  Movement in provisions          
5 865  12 697  Share appreciation rights expense recognised over vesting period  32       
      Other adjustments:           
145 765  122 964  Finance cost   6.6  13  14 
(12 647) (10 139) Finance income   6.5  (5 097) (3 438)
–  –  Dividends received     (80 000) (100 000)
–  –  Share appreciation rights expense settled in cash           
–  (4 490) Government grants          
(47 115) (56 938) Taxes paid  26  (9 184) (8 696)
      Working capital adjustments          
(43 578) 24 269  (Increase)/Decrease in inventories          
(36 747) (91 298) (Increase)/Decrease in trade and other receivables     (8 835) 13 426 
(81 902) 30 799  (Decrease)/Increase in trade and other payables     (79) 19 
276 956  673 448  Net cash flows from operating activities     21 088  36 237 

CONSOLIDATED STATEMENTS OF CASH FLOWS

for the year ended 30 June 2017
GROUP       COMPANY
                 
2017
R’000
2016
R’000
   Notes 2017
R’000
2016
R’000
276 956  673 448  Net cash flows from operating activities     21 088  36 237 
      Investing activities           
58 941  45 533  Proceeds from sale of property, plant and equipment and other assets     –  950 
(11 232) 27 833  Realised foreign exchange (loss)/gain  6.2 - 6.3       
12 647  10 139  Interest received  6.5  5 097  3 438 
–  (2 550) Acquisition of controlling interest in Clover Good Hope Proprietary Limited          
–  (6 610) Acquisition of controlling interest in Clover Frankies Proprietary Limited          
10 275  –  Disposal of controlling interest in Lactolab Proprietary Limited          
(29 639) –  Acquisition of controlling interest in Clover Pride Proprietary Limited  3.1       
3 854  –  Cancellation of a finance lease          
–  –  Dividends received     130 000  50 000 
–  16 097  Government grants received recognised against property, plant and equipment and expenses          
(316 883) (366 665) Capital expenditure: tangible assets          
(5 671) (56 406) Capital expenditure: intangible assets          
(277 708) (332 629) Net cash flows (used in)/from investing activities     135 097  54 388 
      Financing activities          
(145 765) (122 964) Interest paid  6.6  (13) (14)
(115 230) (108 755) Dividends paid     (114 802) (108 755)
(4 440) –  Non-controlling interest acquired in Clover Frankies Proprietary Limited  3.2       
(3 854) –  Cancellation of a finance lease          
(285 668) (254 646) Repayment of borrowings          
496 975  273 939  Proceeds from borrowings          
(57 982) (212 426) Net cash flows (used in)/from financing activities     (114 815) (108 769)
(58 734) 128 393  Net (decrease)/increase in cash and cash equivalents     41 370  (18 144)
(474) 242  Net foreign exchange difference          
604 071  475 436  Cash and cash equivalents at the beginning of the year     21 871  40 015 
544 863  604 071  Cash and cash equivalents at the end of the year  18  63 241  21 871 
Scroll
downloads
Integrated Report
Annual Financial Statements
PRODUCT GALLERY
AGM

Date: Monday, 28 November 2017 at 10am
Venue: Clover Headquarters
 Notice to AGM
  Proxy

CONTACT

Head Office
200 Constantia Drive, Constantia Kloof,
1709, Johannesburg
Tel: +27 (0)11 471 1400

downloads
Integrated Report
Annual Financial Statements
PRODUCT GALLERY
AGM

Date: Monday, 28 November 2017 at 10am
Venue: Clover Headquarters
 Notice to AGM
  Proxy

CONTACT

Head Office
200 Constantia Drive, Constantia Kloof,
1709, Johannesburg
Tel: +27 (0)11 471 1400

Sitemap
Disclaimer
 
Copyright Clover Limited 2017
Sitemap    
Disclaimer   Copyright Clover Limited 2017